Showing results (51-60 of 56) with videos related to
Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
NPJ Precision Oncology|June 16, 2026
Patient-derived three-dimensional lung tumor models to evaluate response to therapyKayla F Goliwas, Aakash Desai, Kenneth P Hough, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 2015
A Phase I/II Study of the mTOR Inhibitor Everolimus in Combination with HyperCVAD Chemotherapy in Patients with Relapsed/Refractory Acute Lymphoblastic LeukemiaNaval Daver, Yanis Boumber, Hagop Kantarjian, et al.Oncogenesis|March 16, 2021
Musashi-2 (MSI2) regulates epidermal growth factor receptor (EGFR) expression and response to EGFR inhibitors in EGFR-mutated non-small cell lung cancer (NSCLC)Petr Makhov, Igor Bychkov, Bulat Faezov, et al.Proceedings of the National Academy of Sciences of the United States of America|June 9, 2016
Musashi-2 (MSI2) supports TGF-β signaling and inhibits claudins to promote non-small cell lung cancer (NSCLC) metastasisAlexander E Kudinov, Alexander Deneka, Anna S Nikonova, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 8, 2024
A Multicenter Open-Label Randomized Phase II Study of Osimertinib With and Without Ramucirumab in Tyrosine Kinase Inhibitor-Naïve EGFR-Mutant Metastatic Non-Small Cell Lung Cancer (RAMOSE trial)Xiuning Le, Jyoti D Patel, Elaine Shum, et al.Journal of the National Comprehensive Cancer Network : JNCCN|October 17, 2018
NCCN Guidelines Insights: Small Cell Lung Cancer, Version 2.2018Gregory P Kalemkerian, Billy W Loo, Wallace Akerley, et al.Pageof 6